This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

U.S. BioEnergy Failing to Find the Green

U.S. BioEnergy's (USBE) stock price has not been a positive recipient of the green initiative that continues to sweep across the nation. After a quick pop in 2006 to $17.70, the stock has been in a volatile downtrend since its retest of $16 in April 2007.

While I normally do not base my short trading decisions on fundamental analysis, it appears that investors who are interested in ethanol companies are more focused on the two major ethanol producers rather than taking the speculative approach of investing strongly in potential success stories.

Investors' appetite for risk in this group appears low, and this is being reflected in the stock prices of some of the smaller players.

Since the test of $16 in April, distribution pressure has been strong in shares of U.S. BioEnergy. This pressure appears to abate as the stock price approaches $10, but a descending triangle pattern is now forming. This type of technical pattern forms when investors try to support a price at a particular level, but are unable to attract new buyers as the price appreciates.

When stocks rally but volume does not pick up on the buy side, tests of resistance usually lead to a retest of the lows. As each new reversal from support leads to a lower high, a descending triangle forms.

This technical pattern tends to be bearish because investors become less confident to buy resistance. They are confident to buy support, but not resistance. The bears will likely take control if the most recent support of the descending triangle fails to hold.

If support breaks, investors who are long U.S. BioEnergy would most likely sell shares in order to minimize their capital loss, which in turn would create even stronger distribution pressure.

The ideal setup for this trade would be an entry at $11.20, with a stop at $12.25. The first profit target will be placed at $10.15 to satisfy a 1-to-1 reward/risk ratio, and partial profits could be taken here.

The final profit target will be determined if the price trades below $9.80. If shares of U.S. BioEnergy move under $9.80 without first offering an entry, this trade setup is no longer valid.

Shares closed at $10.52 Monday.


U.S. BioEnergy (USBE) -- Daily


Update on a Current Pick

Odyssey Healthcare (ODSY) traded below $9.55 before offering an entry at $10.25, invalidating the short setup. So this name has been taken off the Watch List.

At the time of publication, Schumacher had no positions in stocks mentioned, although holdings can change at any time.

Chris Schumacher is a financial trader, speaker, writer and co-author of Techniques of Tape Reading. While Schumacher cannot offer specific investment or trading advice, he appreciates your feedback; click here to send him an email.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,122.01 +15.31 0.09%
S&P 500 2,000.12 +0.10 0.00%
NASDAQ 4,569.6210 -1.0160 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs